Skip to main content
About K2bio

A hybrid CRO scaling the peaks of biopharma research

K2bio is a hybrid Contract Research Organization (CRO) enabling early-stage life science companies to develop the next generation of innovative therapies.

Our mission is to provide comprehensive help and support along the way.

We offer a state-of-the-art facility with experienced research managers and staff and an on-site vivarium. Our mix of private and shared research laboratory space offers affordable access for early-stage biopharmaceutical companies. In addition, our team provides guidance and phase-appropriate regulatory oversight throughout the product research and development lifecycle.

Simply put, we handle the business end of projects while our partners focus on what is most important: science.

It’s been a long-time dream of mine to scale the highest peaks of K2, the most technically challenging mountain climb in the world. While a treacherous journey, I can imagine no more extraordinary view than that from the top. Biopharmaceutical research is much like scaling K2—complex, challenging, and well worth the climb.

Kieron Jones

CEO of K2bio

It’s been a long-time dream of mine to scale the highest peaks of K2, the most technically challenging mountain climb in the world. While a treacherous journey, I can imagine no more extraordinary view than that from the top. Biopharmaceutical research is much like scaling K2—complex, challenging, and well worth the climb.

Kieron Jones

CEO of K2bio